Clinical Trial Update: Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

View source ↗

Summary

The clinical trial NCT03585946 investigating outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stevens-johnson Syndrome
• Toxic Epidermal Necrolysis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis | Status: WITHDRAWN